Walleye Capital LLC Kura Oncology, Inc. Transaction History

Walleye Capital LLC

$23.6 Billion
Q2 2025

A detailed history of Walleye Capital LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 414,322 shares of KURA stock, worth $2.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

414,322

Previous 504,857 17.93%

Holding current value

$2.57 Million

Previous $3.33 Million 28.27%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$5.55 - $6.92 $502,469 - $626,502	-90,535 Reduced 17.93%	414,322 $2.39 Million
Q1 2025 May 14, 2025	SELL	$6.6 - $9.05 $207,642 - $284,722	-31,461 Reduced 5.87%	504,857 $3.33 Million
Q4 2024 Feb 13, 2025	SELL	$8.51 - $19.21 $298,249 - $673,252	-35,047 Reduced 6.13%	536,318 $4.67 Million
Q3 2024 Nov 14, 2024	BUY	$18.57 - $23.23 $9.22 Million - $11.5 Million	496,284 Added 661.0%	571,365 $11.2 Million
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $143,237 - $187,769	-8,171 Reduced 9.81%	75,081 $1.55 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $506,068 - $887,316	37,710 Added 82.8%	83,252 $1.78 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $1.66 Million - $3.15 Million	-219,351 Reduced 82.81%	45,542 $654,000
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $1.54 Million - $2.16 Million	182,221 Added 220.41%	264,893 $2.42 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $795,304 - $1.16 Million	82,672 New	82,672 $874,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $3.22 Million - $5.21 Million	268,074 New	268,074 $3.66 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $323,665 - $455,902	-20,990 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $437,641 - $627,181	20,990 New	20,990 $438,000
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $822,866 - $1.01 Million	-59,932 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $997,867 - $1.31 Million	59,932 New	59,932 $1.05 Million

Others Institutions Holding KURA

# of Institutions

189

Shares Held

79.5M

Call Options Held

53.6K

Put Options Held

42.8K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $415M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Kura Oncology, Inc. Transaction History